FINANCIAL CONSULATE, INC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1624510
HUNT VALLEY, MD
Position in ADPT
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$321
+$321 QoQ
Shares Held
4
-60.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 70 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FINANCIAL CONSULATE, INC holds $527,453 across 14 Diagnostics & Research names. ADPT ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,116 | $403,055 | |
| 2 | WAT |
Waters Corp /De/
|
149 | $55,880 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
62 | $31,084 | |
| 4 | QGEN |
Qiagen N.V.
|
396 | $15,483 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
30 | $5,796 | |
| 6 | A |
Agilent Technologies, Inc.
|
43 | $5,711 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
2 | $2,555 | |
| 8 | DGX |
Quest Diagnostics Inc
|
10 | $2,119 |
All Filings in ADPT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $321 | 15 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | — | 40 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | — | 40 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | — | 40 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||